Hancock Mark J, Maher Christopher G, Latimer Jane, McLachlan Andrew J, Cooper Chris W, Day Richard O, Spindler Megan F, McAuley James H
Back Pain Research Group, University of Sydney, PO Box 170, Lidcombe, NSW, 1825, Australia.
BMC Musculoskelet Disord. 2005 Nov 10;6:57. doi: 10.1186/1471-2474-6-57.
Acute low back pain is a common condition resulting in pain and disability. Current national and international guidelines advocate general practitioner care including advice and paracetamol (4 g daily in otherwise well adults) as the first line of care for people with acute low back pain. Non-steroidal anti-inflammatory drugs (NSAIDs) and spinal manipulative therapy (SMT) are advocated in many guidelines as second line management options for patients with acute low back pain who are not recovering. No studies have explored the role of NSAIDs and/or SMT in addition to first line management for acute low back pain. The primary aim of this study is to investigate if NSAIDs and/or SMT in addition to general practitioner advice and paracetamol results in shorter recovery times for patients with acute low back pain. The secondary aims of the study are to evaluate whether the addition of SMT and/or NSAIDs influences pain, disability and global perceived effect at 1, 2, 4 and 12 weeks after onset of therapy for patients with significant acute low back pain.
METHODS/DESIGN: This paper presents the rationale and design of a randomised controlled trial examining the addition of NSAIDs and/or SMT in 240 people who present to their general practitioner with significant acute low back pain.
急性腰痛是一种常见疾病,会导致疼痛和功能障碍。当前的国家和国际指南提倡由全科医生进行治疗,包括提供建议以及使用对乙酰氨基酚(身体健康的成年人每日4克),作为急性腰痛患者的一线治疗方案。许多指南提倡将非甾体抗炎药(NSAIDs)和脊柱推拿疗法(SMT)作为未康复的急性腰痛患者的二线管理选择。尚无研究探讨除急性腰痛一线管理之外,NSAIDs和/或SMT的作用。本研究的主要目的是调查除全科医生的建议和对乙酰氨基酚之外,NSAIDs和/或SMT是否能使急性腰痛患者的恢复时间更短。该研究的次要目的是评估对于患有严重急性腰痛的患者,在治疗开始后的1、2、4和12周,添加SMT和/或NSAIDs是否会影响疼痛、功能障碍和整体感知效果。
方法/设计:本文介绍了一项随机对照试验的基本原理和设计,该试验对240名因严重急性腰痛就诊于全科医生的患者添加NSAIDs和/或SMT进行研究。